Urban Supreme System

Today's sales statistics of Snow Skin Cream did not surprise Su Zhe.

Although sales have increased a lot, the magnitude is not too great. Of course, this is only compared to the previous increase speed of Snow Skin Cream.

If you compare the sales volume of Snow Skin Cream with other cosmetics, the improvement rate of Snow Skin Cream is many times faster.

However, due to the production capacity problem of Yadai Group, even if the market demand for Xuejia Cream is greater, sales volume cannot increase too much at once. After all, the production capacity is here.

If the production capacity of Snow Skin Cream is only one million bottles a day, it is impossible to sell two million bottles a day. This is obviously impossible.

Therefore, the improvement of Snow Muscle Cream was completely within Su Zhe's expectation, so naturally there was no big surprise.

After reading the sales statistics of Snow Skin Cream, he opened another email, which was sent by Li Changhua.

It turned out that the email sent by Li Changhua was information from a large pharmaceutical factory for Su Zhe to use as a reference, because Li Changhua was planning to let Changhua Pharmaceutical acquire this pharmaceutical factory to increase the production capacity of drugs.

As long as Su Zhe thinks there are no problems, the acquisition can start.

No wonder Li Changhua sent him email 3. It was originally for the purpose of acquiring a pharmaceutical factory. However, as the pharmaceutical factory provides more and more therapeutic potions, Changhua Pharmaceutical's production capacity does need to be increased so that it can meet production needs. .

Otherwise, so much healing potion will be wasted. If it cannot be used, it will be the biggest waste.

Therefore, Li Changhua has been thinking of ways. to increase the production capacity of Changhua Pharmaceutical.

Recently he has been looking for suitable acquisition targets. In order to do so in the shortest possible time. It can improve the production capacity of Changhua Pharmaceutical.

And since Li Changhua will send the information of this pharmaceutical factory to Su Zhe for reference, it means that Li Changhua also feels that the conditions of this pharmaceutical factory meet Changhua Pharmaceutical's acquisition needs, so he will let him make the decision.

Su Zhe also knew that it was indeed very urgent for Changhua Pharmaceutical to increase its production capacity, and the shorter the time, the better, so he responded accordingly. Don't dare to be careless.

He immediately opened the attachment and began to check the pharmaceutical factory's information so that he could make a decision so that Li Changhua could start making arrangements.

This pharmaceutical factory Li Changhua is interested in,

Qinhai Pharmaceutical Group is a large-scale comprehensive modern pharmaceutical enterprise covering an area of ​​more than one million square meters and currently employs more than 2,000 people.

Qinhai Pharmaceutical Group has a production base covering an area of ​​one million square meters for preparations, biotechnology, chemical synthesis, antibiotic fermentation, etc., as well as a modern production workshop with domestically advanced production equipment. Even the world's leading production capacity and production level.

It has the annual production capacity of 15,000 tons of raw materials, 2 billion powder injections, 14 billion tablets, 10 billion capsules, 100 million water injections, and 100 million bottles of large-volume injections.

This is information obtained by Li Changhua during an on-the-spot investigation, so it is highly authentic.

This is Qinhai Pharmaceutical Group. Both the floor space and the scale of production are much larger than those of Xinjing Pharmaceutical previously acquired.

Moreover, the production capacity of Qinhai Pharmaceutical Group still has a lot of room for improvement.

According to the data returned by Li Changhua and professionals, the production capacity of Qinhai Pharmaceutical Group can be increased by another 30% in a short period of time.

Even without increasing production capacity, Qinhai Pharmaceutical Group's current production capacity is already very good.

The only shortcoming is that the address of Qinhai Pharmaceutical Group is not in the province, but more than 2,000 kilometers away from the province.

But this doesn't matter. After all, the drugs produced by Changhua Pharmaceutical are sold across the country and even the world, not just within the province.

So it doesn't matter that the address of this pharmaceutical factory is not in the province, and there won't be any inconvenience.

Moreover, if Changhua Pharmaceutical has branches outside the province, the drugs produced can also be sold directly in other provinces without having to transport them back.

Because Liu's pharmacy chain is spread all over the country, no matter where the branches are in the country, Liu's pharmacy will not be affected, and it can even save some transportation costs and time, which is more convenient.

However, the scale of Qinhai Pharmaceutical Group is higher than that of Xinjing Pharmaceutical Factory. If you want to acquire Qinhai Pharmaceutical Group, the price will naturally not be much lower.

At that time, Changhua Pharmaceutical acquired Xinjing Pharmaceutical Factory and used a loan of 2.5 billion to acquire Xinjing Pharmaceutical Factory.

The Qinhai Pharmaceutical Group has expressed its intention to transfer, and all shareholders have expressed that they can sell their shares. At the price that Li Changhua negotiated with them, Changhua Pharmaceutical will need to pay to acquire all the shares of Qinhai Pharmaceutical Group. 2.8 billion in cash and 2 billion in liabilities.

In other words, if it wants to acquire Qinhai Pharmaceutical Group, Changhua Pharmaceutical will need to pay 4.8 billion to get all the shares.

The purchase price of Qinhai Pharmaceutical Group is almost twice as high as that of Xinjing Pharmaceutical Factory.

However, after investigation, the acquisition of Qinhai Pharmaceutical Group for 4.8 billion was still worth this price.

If Qinhai Pharmaceutical Group can be acquired, after integration, the overall production capacity of Changhua Pharmaceutical can be increased by at least 50%.

Moreover, Qinhai Pharmaceutical Group's production capacity still has a lot of room for improvement. After initial improvement, Qinhai Pharmaceutical Group's own production capacity can be increased by another 30%.

Therefore, the acquisition of Qinhai Pharmaceutical Group is very helpful for Changhua Pharmaceutical to increase its drug production capacity.

This is why Li Changhua took a fancy to Qinhai Pharmaceutical Group and collected detailed information so that Su Zhe could use it as a reference to make a decision.

At present, Changhua Pharmaceutical's cash reserves can also be used to make acquisitions with 4.8 billion in cash.

However, if Changhua Pharmaceutical spends 4.8 billion in cash to acquire Qinhai Pharmaceutical Group, it will not be able to borrow 2.5 billion from the bank in a short time to acquire Xinjing Pharmaceutical Factory. Paid off.

Originally, Changhua Pharmaceutical planned to repay the loan within this month. If it wanted to acquire Qinhai Pharmaceutical Group, it would not be able to do so.

Of course, if Changhua Pharmaceutical wants to acquire Qinhai Pharmaceutical Group, it does not need to spend 4 billion at once. It can first spend 2.8 billion in cash to acquire the shareholders' shares. As for the group's liabilities, it can be repaid slowly. Yes, it's not urgent.

However, Su Zhe didn't want to cause trouble in the future. He wanted to resolve all the liabilities of Qinhai Pharmaceutical Group while making the acquisition, so as to avoid trouble in the future.

Therefore, if you want to acquire Qinhai Pharmaceutical Group, you will need 4.8 billion yuan in funds. (To be continued...)

... ()